Linda Wilhelmina Van Laake

Linda Wilhelmina Van Laake

Auto-generated profile, based on publicly available information

Linda Wilhelmina Van Laake

Department of Cardiology and Transplantation Center Utrecht, University Medical Center Utrecht, Utrecht, The Netherlands

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 February 2019 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
SCSandra Crnko
Sandra Crnko
BPBastiaan C. Du Pré
Bastiaan C. Du Pré
JSJoost P. G. Sluijter
Joost P. G. Sluijter
LLLinda W. Van Laake
Linda W. Van Laake

31 May 2021 in European Heart Journal
Verified
Journal Article
Open access
PDF file
HBHeerajnarain Bulluck
Heerajnarain Bulluck
VPValeria Paradies
Valeria Paradies
EBEmanuele Barbato
Emanuele Barbato
ABAndreas Baumbach
Andreas Baumbach
HBHans Erik Bøtker
Hans Erik Bøtker
DHDerek Hausenloy
Derek Hausenloy
A substantial number of chronic coronary syndrome (CCS) patients undergoing percutaneous coronary intervention (PCI) experience periprocedural myocardial injury or infarction. Accurate diagnosis of these PCI-related complications is required to guide further management given that their occurrence may be associated with increased risk of major adverse cardiac events (MACE). Due to lack of scientific data, the cut-off thresholds of post-PCI cardiac troponin (cTn) elevation used for defining periprocedural myocardial injury and infarction, have been selected based on expert consensus opinions, and their prognostic relevance remains unclear. In this Consensus Document from the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI), we recommend, whenever possible, the measurement of baseline (pre-PCI) cTn and post-PCI cTn values in all CCS patients undergoing PCI. We confirm the prognostic relevance of the post-PCI cTn elevation >5× 99th percentile URL threshold used to define type 4a myocardial infarction (MI). In the absence of periprocedural angiographic flow-limiting complications or electrocardiogram (ECG) and imaging evidence of new myocardial ischaemia, we propose the same post-PCI cTn cut-off threshold (>5× 99th percentile URL) be used to define prognostically relevant ‘major’ periprocedural myocardial injury. As both type 4a MI and major periprocedural myocardial injury are strong independent predictors of all-cause mortality at 1 year post-PCI, they may be used as quality metrics and surrogate endpoints for clinical trials. Further research is needed to evaluate treatment strategies for reducing the risk of major periprocedural myocardial injury, type 4a MI, and MACE in CCS patients undergoing PCI.

19 December 2017 in EMBO Reports
Verified
Journal Article
Open access
PDF file
PDPieterjan Dierickx
Pieterjan Dierickx
LLLinda W Van Laake
Linda W Van Laake
NGNiels Geijsen
Niels Geijsen
The circadian clock is an evolutionarily conserved timekeeper that adapts body physiology to diurnal cycles of around 24 h by influencing a wide variety of processes such as sleep‐to‐wake transitions, feeding and fasting patterns, body temperature, and hormone regulation. The molecular clock machinery comprises a pathway that is driven by rhythmic docking of the transcription factors BMAL1 and CLOCK on clock‐controlled output genes, which results in tissue‐specific oscillatory gene expression programs. Genetic as well as environmental perturbation of the circadian clock has been implicated in various diseases ranging from sleep to metabolic disorders and cancer development. Here, we review the origination of circadian rhythms in stem cells and their function in differentiated cells and organs. We describe how clocks influence stem cell maintenance and organ physiology, as well as how rhythmicity affects lineage commitment, tissue regeneration, and aging.

28 February 2022 in The Lancet Oncology
Verified
Journal Article
Closed access
MPMarkella I Printezi
Markella I Printezi
AKAoife B Kilgallen
Aoife B Kilgallen
MBMarinde J G Bond
Marinde J G Bond
UŠUrška Štibler
Urška Štibler
MPMarrit Putker
Marrit Putker
LLLinda W van Laake
Linda W van Laake

28 August 2026 in European Heart Journal
Verified
Journal Article
Closed access
LKLars Valeur Köber
Lars Valeur Köber
MAMarianna Adamo
Marianna Adamo
ARAnne-Christine Ruwald
Anne-Christine Ruwald
DTDaniela Tomasoni
Daniela Tomasoni
LALisa J Anderson
Lisa J Anderson
TATimur Abdullaev
Timur Abdullaev

23 May 2017 in EMBO Reports
Verified
Journal Article
Open access
PDF file
PDPieterjan Dierickx
Pieterjan Dierickx
MVMarit W Vermunt
Marit W Vermunt
MMMauro J Muraro
Mauro J Muraro
MCMenno P Creyghton
Menno P Creyghton
PDPieter A Doevendans
Pieter A Doevendans
LLLinda W Van Laake
Linda W Van Laake
Cell‐autonomous circadian oscillations strongly influence tissue physiology and pathophysiology of peripheral organs including the heart, in which the circadian clock is known to determine cardiac metabolism and the outcome of for instance ischemic stress. Human pluripotent stem cells represent a powerful tool to study developmental processes in vitro, but the extent to which human embryonic stem (ES) cell‐derived cardiomyocytes establish circadian rhythmicity in the absence of a systemic context is unknown. Here we demonstrate that while undifferentiated human ES cells do not possess an intrinsic functional clock, oscillatory expression of known core clock genes emerges spontaneously during directed cardiac differentiation. We identify a set of clock‐controlled output genes that contain an oscillatory network of stress‐related transcripts. Furthermore, we demonstrate that this network results in a time‐dependent functional response to doxorubicin, a frequently used anti‐cancer drug with known cardiotoxic side effects. Taken together, our data provide a framework from which the effect of oscillatory gene expression on cardiomyocyte physiology can be modeled in vitro, and demonstrate the influence of a functional clock on experimental outcome. Synopsis The circadian clock is important for proper heart function. This study describes the functional implications of the gradual emergence of a clock during directed cardiac differentiation of human embryonic stem cells. Human embryonic stem cells do not have a functional circadian clock. A functional circadian clock emerges during directed cardiac differentiation. Stem cell‐derived cardiomyocytes possess an oscillatory stress‐related transcriptional network. Stem cell‐derived cardiomyocytes respond to doxorubicin in a time‐dependent circadian pattern.